Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice
- PMID: 1907221
- PMCID: PMC2393081
Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice
Abstract
Mice infected with Trypanosoma cruzi, but parasitologically cured after specific chemotherapy, continued to exhibit positive indirect immunofluorescence serological tests 3-6 months after the therapy. Treatment of trypanosome antigens with monospecific antisera produced in rabbits, and examination by immunoelectron-microscopy following peroxidase labelling disclosed the presence of membrane deposits in cell processes in the spleens of the mice. Similar deposits were observed in the external membranes of T. cruzi amastigotes in the spleens of acutely infected mice, but not in normal control mice. No reaction occurred in tissues not previously treated with the monospecific anti-T. cruzi serum. Positive cells in treated and cured mice, as well as in the not cured or untreated control mice, were located in germinal centres of the splenic white pulp and presented long and branching cytoplasmic processes, which are indicative of dendritic cells of the lymphoid follicles of the spleen.
Similar articles
-
[Chronic Chagas' disease: effects of treatment nn the levels of antibodies to crude and partially purified Trypanosoma cruzi antigens].Bol Chil Parasitol. 1998 Jan-Jun;53(1-2):3-9. Bol Chil Parasitol. 1998. PMID: 9830716 Spanish.
-
Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.Exp Parasitol. 2010 Feb;124(2):172-80. doi: 10.1016/j.exppara.2009.09.006. Epub 2009 Sep 9. Exp Parasitol. 2010. PMID: 19747482
-
Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.Bull World Health Organ. 1985;63(4):721-6. Bull World Health Organ. 1985. PMID: 3936634 Free PMC article.
-
[Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].Medicina (B Aires). 1999;59 Suppl 2:166-70. Medicina (B Aires). 1999. PMID: 10668259 Review. Spanish.
-
Chagas disease. American trypanosomiasis.Infect Dis Clin North Am. 1993 Sep;7(3):487-502. Infect Dis Clin North Am. 1993. PMID: 8254156 Review.
Cited by
-
Changes in Trypanosoma cruzi-specific immune responses after treatment: surrogate markers of treatment efficacy.Clin Infect Dis. 2009 Dec 1;49(11):1675-84. doi: 10.1086/648072. Clin Infect Dis. 2009. PMID: 19877967 Free PMC article. Clinical Trial.
-
Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi.Antimicrob Agents Chemother. 1998 Oct;42(10):2549-56. doi: 10.1128/AAC.42.10.2549. Antimicrob Agents Chemother. 1998. PMID: 9756754 Free PMC article.
-
Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.Cochrane Database Syst Rev. 2014 May 27;2014(5):CD003463. doi: 10.1002/14651858.CD003463.pub2. Cochrane Database Syst Rev. 2014. PMID: 24867876 Free PMC article.
-
Use of the EIE-recombinant-Chagas-biomanguinhos kit to monitor cure of human Chagas' disease.J Clin Lab Anal. 2002;16(3):132-6. doi: 10.1002/jcla.10028. J Clin Lab Anal. 2002. PMID: 11968049 Free PMC article.
-
Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.Mem Inst Oswaldo Cruz. 2015 Feb;110(1):86-94. doi: 10.1590/0074-02760140260. Epub 2015 Jan 23. Mem Inst Oswaldo Cruz. 2015. PMID: 25742267 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical